CEACAM5 and neoplasm: Carcinoembryonic antigen (CEA) is a well-established, cost-effective biological tumor marker used in colorectal cancer since 1965.9 Its current use is restrained to helping the diagnosis of relapse in localized cancer and monitoring chemotherapy efficacy in the metastatic setting.